{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:24:27Z","timestamp":1791239067828,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.diagmicrobio.2012.02.018","type":"journal-article","created":{"date-parts":[[2012,4,10]],"date-time":"2012-04-10T01:47:06Z","timestamp":1334022426000},"page":"144-148","source":"Crossref","is-referenced-by-count":60,"title":["Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility"],"prefix":"10.1016","volume":"73","author":[{"given":"Shawn R.","family":"Lockhart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naureen","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol B.","family":"Bolden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio E.","family":"DeBess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Marsden-Haug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Worhle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rameshwari","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie R.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0005","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S1130-1406(08)70019-6","article-title":"Diversity of the Cryptococcus neoformans\u2013Cryptococcus gattii species complex","volume":"25","author":"Bovers","year":"2008","journal-title":"Rev Iberoam Mycol"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0010","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/597306","article-title":"Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States","volume":"199","author":"Byrnes","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0015","doi-asserted-by":"crossref","first-page":"e1000850","DOI":"10.1371\/journal.ppat.1000850","article-title":"Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States","volume":"6","author":"Byrnes","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0020","doi-asserted-by":"crossref","first-page":"e16936","DOI":"10.1371\/journal.pone.0016936","article-title":"Clonality and \u03b1\u2014a recombination in the Australian Cryptococcus gattii VGII population\u2014an emerging outbreak in Australia","volume":"6","author":"Carriconde","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0025","first-page":"865","article-title":"Emergence of Cryptococcus gattii\u2013Pacific Northwest, 2004\u20132010","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0030","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s10096-004-1136-2","article-title":"In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia","volume":"23","author":"Chandenier","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0035","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/313992","article-title":"Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand","volume":"31","author":"Chen","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0732-8893(99)00137-6","article-title":"Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan","volume":"36","author":"Chen","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0045","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1128\/JCM.01271-10","article-title":"In vitro susceptibility of the yeast pathogen Cryptococcus to fluconazole and other azoles varies with molecular genotype","volume":"48","author":"Chong","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0050","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1099\/jmm.0.029025-0","article-title":"In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India","volume":"60","author":"Chowdhary","year":"2011","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0055","series-title":"M27-A3 Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard-third edition","author":"Clinical Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0060","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1128\/AAC.01520-05","article-title":"French Cryptococcosis Study Group Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis","volume":"50","author":"Dannaoui","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0065","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/jac\/dkg399","article-title":"Fluconazole and itraconazole susceptibilities of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India; a need for care","volume":"52","author":"Datta","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0070","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/JCM.00536-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)","volume":"48","author":"Espinel-Ingroff","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0075","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/nature04220","article-title":"Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak","volume":"437","author":"Fraser","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0080","doi-asserted-by":"crossref","first-page":"e28550","DOI":"10.1371\/journal.pone.0028550","article-title":"Whole genome sequence analysis of Cryptococcus gattii in the Pacific Northwest reveals unexpected diversity","volume":"6","author":"Gillece","year":"2011","journal-title":"PLoS. ONE."},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0085","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1469-0691.2008.02021.x","article-title":"In vitro susceptibility of Cryptococcus gattii clinical isolates","volume":"14","author":"Gomez-Lopez","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0090","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1128\/AAC.00746-10","article-title":"In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates","volume":"54","author":"Hagen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0095","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/cid\/cir723","article-title":"Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen","volume":"53","author":"Harris","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0100","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1469-0691.2009.02802.x","article-title":"Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection","volume":"15","author":"Heath","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0105","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.diagmicrobio.2008.07.003","article-title":"Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods","volume":"62","author":"Iqbal","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0110","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/JCM.01505-09","article-title":"Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States","volume":"48","author":"Iqbal","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0115","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/jac\/dkm192","article-title":"Antifungal susceptibility of Cryptococcus neoformans and Cryptococcus gattii isolates from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees in north-western India","volume":"60","author":"Khan","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0120","doi-asserted-by":"crossref","first-page":"17258","DOI":"10.1073\/pnas.0402981101","article-title":"A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)","volume":"101","author":"Kidd","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0125","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/JCM.15.3.535-537.1982","article-title":"Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C)","volume":"15","author":"Kwon-Chung","year":"1982","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0130","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1513\/pats.200907-063AL","article-title":"Cryptococcus","volume":"7","author":"Li","year":"2010","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0135","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3201\/eid1301.060827","article-title":"Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA","volume":"13","author":"MacDougall","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0140","first-page":"1","article-title":"Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii","volume":"12","author":"Meyer","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3201\/eid0902.020246","article-title":"Molecular typing of Iberoamerican Cryptococcus neoformans isolates","volume":"9","author":"Meyer","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0150","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/13693780400029528","article-title":"Cryptococcus gattii: in vitro susceptibility to the new antifungal albaconazole versus fluconazole and voriconazole","volume":"43","author":"Morera-L\u00f3pez","year":"2005","journal-title":"Med Mycol"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0155","doi-asserted-by":"crossref","first-page":"e5862","DOI":"10.1371\/journal.pone.0005862","article-title":"Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties","volume":"4","author":"Ngamskulrungroj","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0160","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","article-title":"Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods","volume":"13","author":"Pfaller","year":"2010","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0175","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/JCM.02437-10","article-title":"Validation of 24-hour posaconazole and voriconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: application of epidemiological cutoff values to results from a global Candida antifungal surveillance program","volume":"49","author":"Pfaller","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0180","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.diagmicrobio.2011.07.007","article-title":"Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method","volume":"71","author":"Pfaller","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.diagmicrobio.2010.08.013","volume":"69","author":"Pfaller","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0170","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/JCM.43.5.2163-2167.2005","article-title":"Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)","volume":"43","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0190","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.00156-08","article-title":"Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus","volume":"52","author":"Rodriguez-Tudela","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0195","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1439-0507.2006.01242.x","article-title":"In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs","volume":"49","author":"Tay","year":"2006","journal-title":"Mycoses"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.01216-08","article-title":"Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans","volume":"53","author":"Thompson","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0205","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1128\/JCM.42.10.4815-4817.2004","article-title":"In vitro antifungal susceptibility of Cryptococcus gattii","volume":"42","author":"Trilles","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0210","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/13693786.2011.602126","article-title":"Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans\/C. gattii species complex","volume":"50","author":"Trilles","year":"2012","journal-title":"Med Mycol"},{"key":"10.1016\/j.diagmicrobio.2012.02.018_bb0215","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1469-0691.2006.01377.x","article-title":"Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values","volume":"12","author":"Turnidge","year":"2006","journal-title":"Clin Microbiol Infect"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889312000831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889312000831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T17:16:31Z","timestamp":1593969391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889312000831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0732889312000831"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2012.02.018","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}